Financial Targets for the Fiscal Year Ending May 2024 under the New Medium-Term Management Plan
First written in FY2021. 5 of 7 entries say "Restated". Latest entry: FY2023.
The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.
- FY2023AchievedAnnual report
「As a result, although it was an interim year, the Company achieved all of its final-year targets for consolidated net sales, consolidated operating profit and consolidated ordinary profit.」
For the new medium-term management plan ending in May 2024, all final-year targets were achieved in the interim year ending May 2023: consolidated net sales of ¥52.0 billion, consolidated operating profit of ¥620 million and consolidated ordinary profit of ¥680 million. - FY2023-Q3RestatedAnnual report
「There were no material changes to the group’s management policies, management strategies or other related matters during the cumulative third quarter of the current consolidated fiscal year.」
It was reconfirmed that there had been no material changes to the management policies and strategies, including the new medium-term management plan ending in May 2024. - FY2023-Q2RestatedAnnual report
「There were no material changes to the Group’s management policies, management strategies or other related matters during the cumulative second quarter of the current fiscal year.」
It was reconfirmed that there had been no material changes to the management policies and strategies, including the new medium-term management plan ending in May 2024. - FY2023-Q1RestatedAnnual report
「There were no material changes to the group’s management policies, management strategies or other related matters during the cumulative first quarter of the current consolidated fiscal year.」
It was reconfirmed that there had been no material changes to the management policies and strategies, including the new medium-term management plan beginning in the fiscal year ending May 2022 and ending in the fiscal year ending May 2024. - FY2022-Q3RestatedAnnual report
「There were no material changes to the group’s management policies, management strategies or other related matters during the cumulative third quarter of the current consolidated fiscal year.」
It was reconfirmed that there had been no material changes to the management policies and strategies, including the new medium-term management plan beginning in the fiscal year ending May 2022 and ending in the fiscal year ending May 2024. - FY2022-Q2RestatedAnnual report
「There were no material changes to the Group’s management policies, management strategies or other related matters during the cumulative second quarter of the current fiscal year.」
It was explicitly stated that there had been no material changes to the management policies and strategies, including the new medium-term management plan beginning in the fiscal year ending May 2022 and ending in the fiscal year ending May 2024. - FY2021First statedAnnual report
「Following the completion of the previous medium-term management plan, the Company formulated a new three-year medium-term management plan in July, beginning with the fiscal year ending May 2022. The plan’s basic policy is to “strengthen the Group’s capabilities in the healthcare field by establishing a structure capable of sustainable growth and pursuing continued earnings expansion.” The key performance targets for the final year, the fiscal year ending May 2024, are consolidated revenue of ¥52,000 million, consolidated operating profit of ¥620 million and consolidated ordinary profit of ¥680 million.」
Following the completion of the previous medium-term management plan, a new three-year plan was formulated, with the fiscal year ending May 2022 as its first year and the fiscal year ending May 2024 as its final year. Its objectives are to build a structure capable of sustainable growth, expand priority business areas and strengthen the Group's capabilities, with targets of consolidated revenue of ¥52.0 billion, consolidated operating profit of ¥620 million and consolidated ordinary profit of ¥680 million.